On Friday, Following U.S. Stocks were among the “Top Gainers”: TherapeuticsMD, Inc. (NYSEMKT:TXMD), Rockwell Collins Inc. (NYSE:COL), Burlington Stores, Inc. (NYSE:BURL), Anthem, Inc. (NYSE:ANTM)
TherapeuticsMD, Inc. (NYSEMKT:TXMD), with shares inclined 1.77%, closed at $5.75.
Rockwell Collins Inc. (NYSE:COL), with shares jumped 1.75%, settled at $93.23.
Burlington Stores, Inc. (NYSE:BURL),, with shares climbed 1.74%, and closed at $58.59, hitting new 52-week high of $58.62.
Anthem, Inc. (NYSE:ANTM), surged 1.73%, and closed at $150.01, hitting 52-week best price of $150.03.
Latest NEWS regarding these Stocks are depicted underneath:
TherapeuticsMD, Inc. (NYSEMKT:TXMD)
TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare corporation, declared its fourth quarter and full-year financial results for the period ending Dec. 31, 2014.
2014 and recent corporate developments:
- Net proceed raised to about $15.0 million in 2014 contrast with about $8.8 million in the preceding year, reflecting a 71 percent raise in product sales.
- Net loss was about $54.2 million in 2014 contrast with about $28.4 million in the preceding year, reflecting the corporation’s raised investment in clinical trials for two phase 3 pipeline products.
- The corporation initiated enrollment of patients in the phase 3 Rejoice Trial for TX-004HR, the VagiCap™ investigational softgel vaginal suppository for treatment of painful intercourse, a symptom of vulvar vaginal atrophy (VVA) due to menopause.
- The corporation continued enrollment of patients in the phase 3 Replenish Trial for TX-001HR, a novel investigational bio-identical estradiol-progesterone combination product candidate.
- The corporation’s intellectual property portfolio grew to comprise a current total of 93 patent filings, 55 of which were filed in international jurisdictions, and comprises 11 U.S. patent allowances or issuances.
- The corporation accomplished the year with no outstanding debt and a cash balance of about $51.4 million, which was further strengthened by an equity offering in February 2015 that generated about $59.1 million in net proceeds.
TherapeuticsMD, Inc. is an innovative healthcare corporation focused on developing and commercializing products exclusively for women. With its patented SYMBODA™ technology platform, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes.
TherapeuticsMD, Inc. operates as a women’s health care product corporation. The corporation manufactures and distributes branded and generic prescription prenatal vitamins, in addition to over-the-counter vitamins and cosmetics.
Rockwell Collins Inc. (NYSE:COL)
Rockwell Collins Inc. (COL), declared it has accomplished the sale of ARINC Aerospace Systems Engineering and Support (ASES LLC) to Field Aviation Inc., a privately held U.S. corporation.
ASES LLC provides aircraft modification, integration and maintenance services, in addition to logistical and sustainment capabilities, for the Department of Defense (DoD), government, commercial, business and private customers.
The sale of ASES, part of the integration plan declared by Rockwell Collins when it purchased ARINC in December 2013, comprises operations in Oklahoma City and about 230 employees.
Rockwell Collins is a pioneer in the development and deployment of innovative communication and aviation electronic solutions for both commercial and government applications.
Burlington Stores, Inc. (NYSE:BURL)
Burlington Stores, Inc. (BURL), a nationally recognized off-price retailer of high-quality, branded apparel at everyday low prices, will make public its fourth quarter and fiscal year 2014 results before the U.S. stock market opens on Tuesday, March 17, 2015. The Corporation will hold a conference call to talk about its results at 8:30 a.m. (Eastern Time) that day.
Burlington Stores, Inc., through its wholly-owned auxiliaries, operates a national chain of off-price retail stores offering ladies’, men’s and children’s apparel and accessories, home goods, baby products and coats, principally under the name Burlington Stores.
Anthem, Inc. (NYSE:ANTM)
Formerly on February 26, Anthem, Inc. (ANTM), declared it has named Michael Malouf as the new president of the Dental business. Malouf will report to Pam Kehaly, president of Anthem Inc.’s Specialty Business and West Region. He will be responsible for managing the profit/loss for the Dental business, comprised of almost 9 million members, with accountability for product development, operations, underwriting, network development and strategy. Malouf will be based in the Eagan, Minnesota office.
Malouf joins Anthem after serving as president and CEO of Dearborn National Insurance Corporation – one of the largest domestic dental network and dental benefits providers in the country. Preceding to that, he was President and CEO of Willis of Illinois, a large insurance consulting firm in Chicago. He joined Willis of Illinois after a long career at MetLife, where he led the corporation’s global strategies and worked in numerous positions in sales, national accounts, employee benefits and marketing.
Anthem, Inc., through its auxiliaries, operates as a health benefits corporation in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. With more than 68 million people served by its associated companies, counting more than 37 million enrolled in its family of health plans, Anthem is one of the nation’s leading health benefits companies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
